We only have this paper's title and publication details.
Read it at the sourceNovel mannoglucogalactan TAP-2a enhances nitric oxide and interleukin release in vitro, suggesting its potential as an immunotherapy agent.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: